Clinical Trials Enrolling Participants

Identifying and Characterizing Preclinical MS

Immune Response Analysis in Lymph Node Tissue

Neurology Data Registry & Biorepository

Intestinal Immunity in Neurologic Disease

AMS05: Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis

A Phase I/III Randomized, Double-blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156/AZD3152 for Pre-exposure Prophylaxis of COVID-19 in Participants with Conditions Causing Immune Impairment

The Brain Shuttle Study

Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis

A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis (CONSONANCE)